COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

COURSE: B.PHARMACY

SEMESTER: 6TH SUBJECT: PHARMACOLOGY-III

CODE: BP602T

SUBJECT TEACHER: MS. KIRAN SAINI

 Chemotherapy  General principles of chemotherapy.  Sulfonamides and cotrimoxazole.  - , , chloramphenicol, macrolides, quinolones and  fluoroquinolins,  tetracycline and aminoglycosides

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 1

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

General principles of chemotherapy This type of therapy is generally called chemotherapy which has come to mean 'treatment of systemic infections with specific drugs that selectively suppress the infecting microorganism without significantly affecting the host.' The basis of selective microbial toxicity is the action of the drug on a component of the microbe (e.g. bacterial ) or metabolic processes (e.g. folate svnthesis) that is not found in the host, or high affinity for certain microbial biomolecules (e.g. trimethoprim for bacterial dihydrofolate reductase). Due to analogy between the malignant cell and the pathogenic microbes, treatment of neoplastic diseases with drugs is also called 'chemotherapy'. Anti biotics These are substances produced by microorganisms, which selectively suppress the growth of or kill other microorganisms at very low concentrations. Antimicrobial agent (AMA) to designate synthetic as well as naturally obtained drugs that attenuate microorganisms. CLASSIFICATION Antimicrobial drugs can be classified in many ways: A. Chemical structure 1. Sulfonamides and related drugs: Sulfadiazine and others, Sulfones-Dapsone (DDS), Paraaminosalicylic acid (PAS) . 2. Oiaminopyrimidines: Trimethoprim, Pyrimethamine. 3. Quinalones: Nalidixic acid, Norfloxacin,Ciprofloxacin, Gatifloxacin, etc. 4. �-Lactam antibiotics: Penicillins, Cephalosporins, , . 5. Tetracyclines: Oxytetracycline, Doxycycline,etc. 6. Nitrobenzene derivative: Chloramphenico: ?. Aminog/ycosides: Streptomycin, Gentamycin,Amikacin, Neomycin, etc. 8. Macrolide antibiotics: Erythromycin, Clanthromycin,Azithromycin, etc. 9. Lincosamide antibiotics: Lincomycin, Clindamycin. 10. Glycopeptide antibiotics: Vancomycir . 1 1 . Oxazolidinone: Linezolid. 1 2. Polypeptide antibiotics: -B, Col�tin,, .

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 2

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

13. Nitrofuran derivatives: Nitrofurantoin, Furc: zolidone. 14. Nitroimidazoles: Metronidazole, Tinidazole etc. 1 5 . Nicotinic acid derivatives: , Pyrczinamide,Ethionamide. 1 6 . Polyene antibiotics. Nystatin, Amphotericin-B, Hamycin. 1 7. Azote derivatives: Miconazole, Clotrimoxzole, Ketoconazole, Fluconazole. 18. Others: Rifampin, Spectinomycin, , Viomycin, Ethambutol, Thiacetazone, Clofazimine, Griseofulvin. B. Mechanism of action 1. Inhibit cell wall synthesis: , Cephalosporins, Cycloserine, , Bacitracin. 2. Cause leakage from cell membranes: Poly-peptides-, , Bacitracin, Polyenes-Amphotericin B, Nystatin, Hamycin. 3. Inhibit protein synthesis: Tetracycline, Chloramphenicol, Erythromycin, Clindamycin, Linezolid. 4. Cause misreading ofm-RNA code and affect permeability: Aminoglycosides-Streptomycin, Gentamicin, etc. Inhibit DNA gyrase: Fluoroquinolones Ciprofloxacin and others. Interfere with DNA function: Rifampin, Metronidazole. - Interfere with DNA synthesis: Acyclovir, Zidovudine. - Interfere with intermediary metabolism: Sulfonamides, Sulfones, PAS, Trimethoprim, Pyrimethamine, Ethambutol. � Type of organisms against which primarily active 1 . Antibacterial: Penicillins, Aminoglycosides, Erythromycin, etc. 2. Antifungal: Griseofulvin, Amphotericin B, Ketoconazole, etc. 3. Antiviral: Acyclovir, Amantadine, Zidovudine, etc. 4. Antiprotozoal: Chloroquine, Pyrimethamine, Metronidazole, Diloxanide, etc. 5. Anthelmintic: Mebendazole, Pyrantel, Niclosamide, Diethyl carbamazine, etc. D. Spectrum of activity Narrow-spectrum Penicillin G, streptomycin

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 3

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

Broad-spectrum Tetracyclines Chloramphenicol Hypersensitivity reactions Practically all AMAs are capable of causing hypersensitivity reactions. These are unpredictable and unrelated to dose. The whole range of reactions from rashes to anaphylactic shock can be produced. The more commonly involved AMAs are-penicillins, cephalosporins, sulfonamides, fluoroquinolones. Drug resistance It refers to unresponsiveness of a microorganismto an AMA, and is akin to the phenomenon of tolerance seen in higher organisms. Natural resistance Some microbes have always been resistant to certain AMAs. They lack the metabolic process or the target site which is affected by the particular drug. Acquired resistance It is the development of resistance by an organism (which was sensitive before) due to the use of an AMA over a period of time. Superinfection (Suprainfection) infection occurring after or on top of an earlier infection, especially following treatment with broad-spectrum antibiotics This refers to the appearance of a new infection as a result of antimicrobial therapy. Use of most AMAs causes some alteration 1:· the normal microbial flora of the body. The normal flora contributes to host defence elaborating substances called bacteriocins which inhibit pathogenic organisms. Further pathogen has to compete with the normal flora for nutrients, etc. to establish itself Superinfections are more common when the defence is compromised. • Corticosteroid therapy • Leukaemias and other malignancies, especially when treated with anticancer drugs • Acquired immunodeficiency syndrome (AIDS • Agranulocytosis • Diabetes, disseminated lupus erythematosus Sulfonamides and cotrimoxazole SULFONAMIDES Sulfonamides were the first antimicrobial agents (AMAs) effective against pyogenic bacterial

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 4

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY infections. Sulfonamido-chrysoidine (Prontosil Red) was one of the dyes included by Domagk to treat experimental streptococcal infection in mice and found it to be highly effective. A large number of sulfonamides were produced and used extensively in the subsequent years, but because of rapid emergence of bacterial resistance and the availability of many safer and more effective antibiotics, their current utility is limited, except in combination with trimethoprim (as cotrimoxazole) (for malaria). All sulfonamides may be considered to derivatives of sulfanilamide (p-aminobenzene sulfonamide). 1 . Short acting ( 4-8 hr ): Sulfadiazine 2. Intermediate acting (8-12 hr ): Sulfamethoxazole 3. Long acting ( -7 days): Sulfadoxine, Sulfamethopyrazine 4. Special purpose sulfonamides: Sulfacetamide sod., Mafenide, Silver sulfadiazine, Sulphsalazine

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 5

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

COTRIMOXAZOLE The fixed dose combination of trimethoprim and sulfamethoxazole is called cotrimoxazole.Trimethoprim is a diaminopyrimidine related to the antimalarial drug pyrimethamine which selectively inhibits bacterial dihydrofolate reductase (DHFRase). Thus, human folate metabolism is not interfered at antibacterial concentrations of trimethoprim. Individually, both sulfonamide and trimethoprim are bacteriostatic, but the combination becomes cidal against many organisms.

Sulfamethoxazole was selected for combining with trimethoprim because both have nearly the same t hal f(- 10 hr). Optimal synergy in case of most organisms is exhibited at a concentration ratio of sulfamethoxazole 20 : trimethoprim 1, the MIC of each component may be reduced by 3- 6 times. This ratio is obtained in the plasma when the two are given in a dose ratio of 5 : 1, because trimethoprim enters many tissues, has a larger. Cotrimoxazole volume of distribution than sulfamethoxazole and attains lower plasma concentration. However, the concentration ratio in many tissues is less than 20 : 1 . Trimethoprim adequately crosses blood-brain barrier and placenta, while sulfamethoxazole has a poorer entry. Moreover, trimethoprim is more rapidly absorbed than sulfamethoxazole--concentration ratios may vary with time. Trimethoprim is 40% plasma protein bound, while sulfamethoxazole is 65% bound. Trimethoprim is partly metabolized in liver and excreted in urine.

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 6

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

Uses 1 . Urinary tract infections 2. Respiratory tract infections 3. Typhoid 4. Bacterial diarrhoeas and dysentery 5. Pneumocystis 6. Chancroid QUINOLONES These are synthetic antimicrobials having a quinolone structure that are active primarily against gram-negative bacteria, though newer fluorinated compounds also inhibit gram-positive ones. The first member Nalidixic acid introduced in mid-1960s had usefulness limited to urinary and g.i. tract infections because of low potency, modest blood and tissue levels, limited spectrum and high frequency of bacterial resistance. at position 7 resulting in derivatives called

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 7

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY fluoroquinolones with high potency, expanded spectrum, slow development of resistance, better tissue penetration and good tolerability.

Nalidixic acid It is active against gram-negative bacteria, especially coliforms: E. coli, Proteus, Klebsiella, Enterobacter, Shigella but not Pseudomonas. It acts by inhibiting bacterial DNA gyrase and is bactericidal. Resistance to nalidixic acid develops rather rapidly. Nalidixic acid is absorbed orally, highly plasma protein bound and partly metabolized in liver: one of the metabolites is active. It is excreted in urine with a plasma t half -8 hrs. Adverse effects These are relatively infrequent, consist mostly of g.i. upset and rashes. Most important toxicity is neurological-headache, drowsiness, vertigo, visual disturbances, occasionally seizures (especially in children). Use 1 . Nalidixic acid is primarily used as a urinary antiseptic, generally as a second line drug in recurrent cases or on the basis of sensitivity reports. 2. It has also been employed in diarrhoea caused by Proteus, E. coli, Shigella or Salmonella, and has special place in resistant Shigella enteritis.

FLUOROQUINOLONES These are quinolone antimicrobials having one or more fluorine substitutions. The 'first generation' fluoroquinolones (FQs) introduced in 1980s have one fluoro substitution. In the 1990s, compounds with additional fluoro and other substitutions have been developed-further extending antimicrobial activity to gram-positive cocci and anaerobes, and/ or confering metabolic stability (longer Ph). These are referred to as'second generation' FQs. Norfloxacin Ciprofloxacin Lomefloxacin Levofloxacin Ofloxacin Pefloxacin

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 8

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

Sparfloxacin Gatifloxacin Moxifloxacin

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 9

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

Penicillin

Scottish biologist and pharmacologist After World War I elected Professor of Bacteriology at the University of London in 1928

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 10

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

Fleming received the Nobel Prize in 1945 Accidentally discovered Penicillin while studying properties of Staphylococci Described the mould as being from the genus Penicillium Named the substance released as Penicillin PENICILLIN WAS BORN 7TH MARCH, 1929 History Mass production of the new drug for use in World War II Penicillin saved many lives during the war that may have been lost due to infected wounds Penicillin was also said to treat diphtheria, gangrene, pneumonia, syphilis and tuberculosis Penicillin- first to be used clinically

Penicillin was the first antibiotic to be used clinically in 1941 . It is a miracle that the least toxic drug of its kind was the first to be discovered.It was originally obtained from the fungus Penicillium notatum, but the present source is a high yielding mutant of P. chrysogenum. C hemistry and properties The penicillin nucleus consists of fused thiazolidine and β-lactam rings to which side chains are attached through an amide linkage. Penicillin G (PnG), having a benzyl side chain atR (benzyl penicillin:is the original penicillin used clinically.

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 11

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 12

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

SEMISYNTHETIC PENICILLINS Semisynthetic penicillins are produced by chemically combining specific side chains (in place of benzyl side chain of PnG) or by incorporating specific precursors in the mould cultures. Thus, procaine penicillin and benzathine penicillin are salts of PnG and not semisynthetic penicillins. The aim of producing semisynthetic penicillins has been to overcome the shortcomings of PnG, which are: 1 . Poor oral efficacy. 2. Susceptibility to penicillinase. 3. Narrow spectrum of activity. 4. Hypersensitivity reactions (this has not been overcome in any preparation). CLASSIFICATION 1 . Acid-resistant alternative to penicillin G Phenoxymethyl penicillin (Penicillin V). 2. Penicillinase-resistant penicillins , . 3. Extended spectrum penicillins (a) : Ampicillin, , . (b) : , . (c) : , . �-/actamase inhibitors ,

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 13

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

BETA-LACTAMASE INHIBITORS beta-lactamases are a family of enzymes produced by many gram-positive and gram-negative bacteria that inactivate β -lactam antibiotics by opening the β -lactam ring. Different β - lactamases differ in their substrate affinities. Three inhibitors of this enzyme clavulanic acid, sulbactam and tazobactam are available for clinical use.

Clavulanic acid Obtained from Streptomyces clavuligerus, it has a β -lactam ring but no antibacterial activity of its own. It inhibits a wide variety (class II to class V) of β -lactamases (but not class I cephalosporinase) produced by both gram-positive and gram-negative bacteria. Clavulanic acid is a 'progressive' inhibitor : binding with �-lactamase is reversible initially, but becomes covalent later-inhibition increasing with time. Called a 'suicide' inhibitor, it gets inactivated after binding to the enzyme. It

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 14

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

CEPHALOSPORINS These are a group of semisynthetic antibiotics derived from '-C' obtained from a fungus Cephalosporium. They are chemically related to penicillins; the nucleus consists of a P- lactam ring fused to a dihydrothiazine ring, (7-aminocephalosporanic acid). By addition of different side chains at position 7 of [3-lactam ring (altering spectrum of activity) and at position 3 of dihydrothiazine ring (affecting pharmacokinetics), a large number of semisynthetic comp ounds have been produced.

First generation: The first-generation cephalosporins act as penicillin G substitutes. They are resistant to the staphylococcal penicillinase and also have activity against Proteus mirabilis, E. coli, and Klebsiella pneumonia

ASBASJS MEMORIAL COLLEGE OF PHARMACY, BELA, Page 15

COURSE: B.PHARMACY SUBJECT: PHARMACOLOGY-III, CODE: BP602 Module 02 CHEMOTHERAPY

Second generation: The second-generation cephalosporins display greater activity against three additional gram-negative organisms: H. influenzae, Enterobacter aerogenes, and some Neisseria species, whereas activity against gram-positive organisms is weaker [Note: The exception to this generalization is the structurally related cephamycin, which has little activity against H. influenzae yet is effective against the anaerobe Bacteroides fragilis

Third generation: These cephalosporins have assumed an important role in the treatment of infectious disease. Although inferior to first-generation cephalosporins in regard to their activity against gram-positive cocci, the third-generation cephalosporins have enhanced activity against gram-negative bacilli, including those mentioned above, as well as most other enteric organisms plus Serratia marcescens. [sef-trye-AKS-own] or [sef-oh-TAKS-eem] have become agents of choice in the treatment of meningitis. [sef-TA-zi-deem] has activity against P. aeruginosa.

Fourth generation: is classified as a fourth-generation cephalosporin and must be administered parenterally. Cefepime has a wide antibacterial spectrum, being active against streptococci and staphylococci (but only those that are methicillin-susceptible). Cefepime is also effective against aerobic gram-negative organisms, such as enterobacter, E. coli, K. pneumoniae, P. mirabilis, and P. aeruginosa.

C. Pharmacokinetics Administration: Many of the cephalosporins must be administered IV or IM. because of their poor oral absorption.

1. Distribution: All cephalosporins distribute very well into body fluids. However, adequate therapeutic levels in the CSF, regardless of inflammation, are achieved only with the third- generation cephalosporins. For example, ceftriaxone or cefotaxime are effective in the treatment of neonatal and childhood meningitis caused by H. influenzae. [se-FA- zo-lin] finds application as a single prophylaxis dose prior to surgery because of